BDBM344289 N-{6-(4-acetylpiperazin-1-yl)-2-[(1-oxidothietan-3-yl)oxy]pyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 183
SMILES: CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CC(C)(C)NC(=O)c23)c(OC2CS(=O)C2)n1
InChI Key: InChIKey=CZWCJBGSWWLKIH-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High affinity nerve growth factor receptor (Homo sapiens (Human)) | BDBM344289 (N-{6-(4-acetylpiperazin-1-yl)-2-[(1-oxidothietan-3...) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.80 | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc. US Patent | US Patent US9777020 (2017) BindingDB Entry DOI: 10.7270/Q2T155R7 | ||||||||||||
More data for this Ligand-Target Pair |